Vidit Gujrathi reacts to Liver Doc criticism after Doctor's Day post; Internet says, ‘Ignore the compounder'
The controversy began on Doctor's Day (July 1), when Vidit posted a selfie with his father, mother, wife, and sister, captioned: 'Happy Doctor's Day to my entire family.'
The online row intensified after an X user inquired about the medical specialisations in Vidit Gujrathi's family. Vidit responded, saying, 'My father is an Ayurvedic migraine specialist, my wife is an MD in homoeopathy, my mom practices cosmetology, and my sister is a physiotherapist.'
However, Dr. Cyriac Abby Philips, widely known as The Liver Doc, quickly replied, 'I'm sorry, but none of them are really doctors,' dismissing their qualifications as not medically legitimate.
The exchange escalated further, with Gujrathi clapping back and telling Dr. Philips to 'stay in his lane and try being useful.'
A user replied, 'Ignore the compounder.'
Another said, "Vidit, you are an influential figure, so you have the responsibility not to spread misinformation. Doctor's day on July 1st is celebrated for Doctors of medical science. Not homeopaths, not ayurvedics or any other professions that have nothing to do with medicine.
I'm sorry, but none of them are really doctors.
So educate yourself and be responsible instead of feeling personally attacked by someone for just pointing out that they are not indeed real doctors."
"Well, Vidit has made an important point here. It shouldn't be up to general people to decide who should be called a doctor or who gets the license to treat patients, that's the government's job. But we can only expect governments to take this responsibility seriously when they are made up of rational people who believe in science-backed practices and not in promoting traditional medicine just because it is popular among the masses," replied another user.
Key Takeaways The exchange highlights the ongoing debate between traditional and modern medicine.
Public figures must navigate the complexities of misinformation and personal responsibility.
Social media can amplify conflicts, turning personal exchanges into broader societal discussions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
34 minutes ago
- Time of India
Niti to review concerns over pharma quality
Niti Aayog is addressing growing quality concerns in India's pharmaceutical industry by convening industry experts for discussions. The aim is to analyze the current state, understand challenges, and improve the quality of Indian pharmaceutical products to meet global standards. A meeting chaired by VK Paul will propose recommendations to ensure alignment with international regulations and patient safety. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads New Delhi: Growing quality concerns in the pharmaceutical industry has prompted government's think tank Niti Aayog to step in. It has called industry experts to hold discussions with them and undertake an analysis of the current state of India's pharmaceutical industry, to understand the challenges faced by them and initiatives taken by them to ensure production of safe and effective the idea to raise quality of Indian pharmaceutical products to global standards, a meeting will be held on Monday under the chairmanship of member health VK Paul "Ensuring high quality production to meet International regulations and standards has been a challenge," said an office memorandum by Niti Aayog said that a rigorous focus on quality is essential to ensure patient safety and trust in public health in the domestic a meeting to be held on Monday, Dr Paul will propose recommendations to ensure that India's pharmaceutical products are at par with global standards, people in the know told to the memorandum, with the strong network of manufacturing units across the country it is essential to invest in and uphold the highest quality standards for are about 3,000 Pharmaceutical companies and 10,500 manufacturing units across the has long been known as the pharmacy of the world , ranking third globally in drug and pharmaceutical and production by to Niti Aayog, India exports to 200 countries.
Time of India
3 hours ago
- Time of India
'Not real doctors'? Chess Grandmaster Vidit Gujrathi fires back in viral Doctor's Day spat
Image credits: X/@TheKhelIndia Indian Chess Grandmaster Vidit Gujrathi has recently been making headlines for his viral spat with a doctor on X. The 30-year-old chess player recently took to X to wish his family a happy National Doctor's Day on July 1st. A social media user with the handle 'TheLiverDoc' commented on Gujrathi's post that none of his family members were "really doctors." Ever since, the two have been engaged in an online verbal war that seems to have no end. On July 1st, Gujrathi posted a photo of his family on X writing, "Happy Doctor's Day to my entire family." When asked about the medical specialities of his family members by a person in the comments, he revealed that his father is an Ayurvedic migraine specialist, his wife is an MD Homoeopathy, his mom practices cosmetology and his sister is a physiotherapist. Sometime later, 'TheLiverDoc' reposted Gujrathi's post writing, "I am sorry but none of them are really doctors." Gujrathi responded strongly to the comment writing, Your entire brand and personality is built on insulting others. While you chase retweets by tearing people down, my family quietly heals lives without needing a spotlight. They've helped more people than your ego can count. Stay in your lane. And for a change, try being useful." 'TheLiverDoc' who claimed to be a certified internist with a doctorate in hepatology and liver transplant medicine then took to the social media platform to pen a detailed response clarifying that he meant no offence to the chess player's family and was making a point from a professional standpoint. He explained how Doctor's Day is celebrated as the birth and death anniversary of Dr Bidhan Chandra Roy, one of India's most revered physicians and how the practitioners of Ayurveda , Homeopathy, Cosmetology and Physiotherapy are not "clinical physicians" and the practices themselves are not "realistic clinical medicine." He added how Gujrathi's ignorance of science and health affects the public perception of realistic healthcare and pseudoscientific practices, adding that the medicines he mentioned were "alternate medicine" that is not proven to work. The man clarified his credentials adding that he has 260 peer-reviewed scientific publications, 4400 citations, and an h-index of 30. "Calling out medical misinformation is what I do apart from being a full-time doctor. I suggest you stay in your lane and discuss more on chess. Sorry for the checkmate. And for a change, talk about chess and try being useful. All the best for your future matches," ended the man. Social media reactions Image credits: X/@theliverdr People on X have been commenting under TheLiverDoc's post condemning his comments on Gujrathi's family and on Ayurveda not being a medicinal practice. "Original healing science of India since ancient times is Ayurveda. Homoeopathy is modern day Ayurveda. Allopathy is a fraud science of which you are a practitioner," wrote a man to TheLiverDoc. "Which "medicines" existed before "science" came to play?" probed another. "Someone celebrates their birthday on X. They: 'Woohoo! Goodbye 30, hello 31!' 🎉 TL Doctor: I am sorry, but you are nearing death. There is nothing scientific about it - just Earth doing another lap around the sun." quipped another X user.
Mint
3 hours ago
- Mint
Aster DM sets sights on pan-India expansion after merger with Quality Care
Aster DM Healthcare's merger with Blackstone-backed Quality Care India Ltd (QCIL) was an inflection point for the hospital chain as it embarks on an ambitious expansion plan, deputy managing director and promoter Alisha Moopen told Mint in an interview. The Bengaluru-based hospital group aims to expand its footprint across the country and become a pan-India healthcare leader in the next ten years, said Moopen. However, even as the company explores further inorganic opportunities, it is treading cautiously. 'It has to make business sense…transactions are hard to execute because Indian markets have become so hot," said Moopen. 'But if there's a great asset at the right price…of course, we'll look at it," she added. Read more: Apollo Hospitals: Simplifying corporate structure could lead to rerating The merged entity Aster DM Quality Care Ltd, jointly controlled by Aster's promoters and Blackstone, is in the fray for the acquisition of Canada's Ontario Teachers Pension Plan (OTPP)-owned Sahyadri Hospitals, according to media reports citing sources. The Pune-based hospital has also reportedly received bids from Manipal Hospitals, Sweden-based investment firm EQT, and Malaysia-based IHH Healthcare. While Moopen declined to comment on the Sahyadri bid, she said that Aster would focus on the brand, reputation, trust and valuation of an asset when evaluating an acquisition. '…for us, we are all about sustainable growth," she said. Aster DM announced in late November 2024 that it was merging with QCIL in a deal that will value the combined entity at $5.08 billion ( ₹43,000 crore). The merger is expected to conclude in the next six months. The deal catapulted the merged entity among the top three hospital chains in India by bed size. The combined entity will have 10,301 beds, doubling from Aster DM's current bed capacity of 5,159. It also opens up new markets for Aster, which already has a strong footprint in Kerala and Karnataka, in new states like Madhya Pradesh, Odisha, Chhattisgarh and Tamil Nadu. 'The transaction is an inflection point for the organization, and it's something which we believe will really set us up to become the gold standard for healthcare here," said Moopen, adding that the hospital chain, which has its roots in Dubai, is 'probably one of the youngest [healthcare] brands in this country". 'We were spending a lot of time just setting up the core and setting the foundation. But now hopefully with this merger, we can really sort of have that exponential growth," said Moopen. Expansion plans The merged entity has plans to grow organically through greenfield and brownfield projects in south and central India where Aster DM and Quality Care have strongholds. The total planned bed addition is over 3,300 beds over the next three years. However, growing pan-India and entering new markets is more challenging, said Moopen. 'It takes a good five to ten years to understand a new market," she said, adding that it's all about understanding regional nuances. However, making inroads through an already established player, via an acquisition or a merger, offers up an opportunity to meaningfully scale up in new markets, she added. 'When the merger was happening, that was one of the biggest advantages we saw. Because it opens up three, four new states for us," said Moopen. '...we said, this is great. We don't have to go in from scratch." Read more: Inside Cipla's battle with 'superbugs' as antibiotic resistance rises in India The company plans to grow organically for the next three to four years in its core markets through strategic bed capacity addition, with a total capex outlay of ₹1,878 crore. However, the company is already eyeing the North India market and hopes to start making inroads in the next two to three years. 'Whether we plan that organically or inorganically will depend on what happens in the next couple of years in terms of the opportunities that come up…we are evaluating all aspects," said Moopen. The company plans to fund its organic growth through internal accruals, and will explore raising debt for its inorganic plans, said Moopen. India's private healthcare space is seeing a spree of expansions and consolidation, with major competitors like Apollo Hospitals, Max Healthcare and Narayana Health announcing large expansion plans for the next four to five years. According to a 2024 report by HSBC Global Research, seven listed hospitals will add 14,000 beds over the course of 3-5 years. Read more: Will Torrent Pharma's big bet on JB Chemicals pay off?
